- 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
- 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载。
- 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
- 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
- 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们。
- 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
- 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
氨溴索注射液治疗对呼吸窘迫综合征新生儿血浆内皮素-1(ET-1)水平的影响研究
精品论文 参考文献
氨溴索注射液治疗对呼吸窘迫综合征新生儿血浆内皮素-1(ET-1)水平的影响研究
陈锋
新津县人民医院 儿科 四川成都 611430
【摘要】 目的:探讨氨溴索注射液治疗对呼吸窘迫综合征新生儿血浆内皮素-1(ET-1)水平的影响 方法:选取2010年9月~2016年1月我院收治的诊断为新生儿ARDS的患儿共66例,按照随机数字法分为观察组和对照组,两组各33例。对照组在常规治疗基础上实施机械通气、抗感染及支持治疗;观察组患者在对照组治疗基础上加用氨溴索注射液。两组患儿分别于治疗前和治疗后第5天抽取动脉血和静脉血分别来测量综合指数以及ET-1水平。结果:在治疗第5天,两组ET-1水平显著低于治疗前,且观察组ET-1(40.09plusmn;10.36)水平改善程度显著优于对照组(49.13plusmn;9.75),差异均有统计学意义(Plt;0.05)结论:氨溴索注射液能有效改善呼吸窘迫综合征患儿的氧合状况,降低其血浆内皮素-1水平。
【关键词】:氨溴索;呼吸窘迫综合征;新生儿;内皮素-1
Ambroxol injection in the treatment of neonatal respiratory distress syndrome plasma angiotensin -1 (ET-1) on the level of influence
Chen Feng
Department of Pediatric, the Peoplersquo;s Hospital of Xinjin County;Chengdu, Sichuan;611430
[Abstract] Objective:Of ambroxol injection in the treatment of respiratory distress syndrome neonatal plasma endothelin-1 (ET-1). Methods: diagnosis of September 2010 to 2016 January in our hospital were selected for a total of 66 cases of neonatal acute respiratory distress syndrome (ARDS) in children, according to randomly divided into observation group and control group, two groups of 33 cases in each group. The control group in the conventional treatment on the basis of implementation of mechanical ventilation, anti infection and supportive treatment; observation group patients in the control group were treated with ambroxol hydrochloride injection. Patients in both groups before treatment and after treatment on the 5th day of arterial and venous blood were measured arterial oxygen partial pressure (PaO2), Alveolar arterial oxygen branch pressure difference (PA-aDO2), oxygen (PaO2 / FiO2) score and the level of ET-1. Results:On the fifth day of treatment, ET-1 levels in two groups were significantly lower than those before treatment, and the observation group of ET-1 (40.09plusmn;10.36) level improved significantly better than the control group (49.13plusmn;975), the differences were statistically significant (Plt;0.05) conclusion: ambroxol injection can effectivel
文档评论(0)